Bone Replacement by Dental Progenitor Cells – Repair or replacement of damaged or destroyed craniofacial tissue
Periodontal disease, edentulism (tooth loss), cysts and malignant tumors are some of the major causes of bone loss in the periodontium. For these patients a long lasting replacement of high quality is essential.
Dental stem cells become increasingly attractive for the use in bone regeneration. In the present invention, non-embryonic stem cells from apical perifollicular tissue (dental neural crest-derived progenitor cells, dNC-PCs) of retained human third molars have been isolated and characterized as osteogenic progenitor cells. The cells have been derived from a tissue that is located in the immediate vicinity of immature developing teeth or wisdom teeth. The living soft tissue residing underneath the dental papilla is clearly distinguished from other tooth tissue, such as dental papilla or follicle. The neural crest-derived and multipotent cells can be stimulated to differentiate into bone-forming cells or craniofacial cells or tissue as well as into nerve tissue. Because the dNC-PCs are neural crest derived and express the corresponding markers, they should be suitable to replace all the neural crest-derived craniofacial tissues.
Further Information: PDF
PROvendis GmbH
Phone: +49 (0)208/94105 10
Contact
Dipl.-Ing. Alfred Schillert
Media Contact
All latest news from the category: Technology Offerings
Newest articles
How Microbial Life Shapes Lime Formation in the Deep Ocean
Microorganisms are everywhere and have been influencing the Earth’s environment for over 3.5 billion years. Researchers from Germany, Austria and Taiwan have now deciphered the role they play in the…
Melting Ice, Shifting Ecosystems: The Pressure Ridge Decline Explained
Analysis of three decades of aerial survey data reveals major changes In the Arctic, the old, multiyear ice is increasingly melting, dramatically reducing the frequency and size of pressure ridges….
Redefining Cancer Science: Rodents, Humans, and the PD-1 Puzzle
Results of a comprehensive analysis refute assumptions that a key immune checkpoint receptor functions the same in rodents and humans The Discovery of PD-1: A Milestone in Cancer Treatment Since…